Scroll back to top

Noninvasive prenatal testing

Close

Noninvasive prenatal testing

MaternIT Kit

New MaterniT specimen collection kit

Introducing the upgraded MaterniT specimen collection kit, featuring new branding for better kit identification and fewer components – including one 10 mL Streck tube instead of two – for improved ease-of-use.

NIPT image

Different NIPTs for different patient needs

No other genetic testing laboratory currently offers as much expertise, experience, and choice in NIPT—noninvasive prenatal testing, also called NIPS or cfDNA (cell-free DNA) screening.

With the 2016 acquisition of Sequenom, creator of the first commercially available NIPT, Integrated Genetics now offers three NIPTs—with more than 1 million tests run in total.

Each NIPT offers different capabilities and/or panels to suit the specific needs of your patients and your practice.

Icon
MaterniT® GENOME

The only clinically validated genome-wide NIPT, screens all 23 chromosome pairs, reporting aneuploidies, large deletions and duplications greater than 7 Mb in addition to select microdeletions; after more than 35,000 tests resulted, more than 29% of all positive findings were only detectable using genome-wide cfDNA, the methodology used by MaterniT GENOME, as compared to traditional NIPT.1

Icon
MaterniT® 21 PLUS

The pioneering NIPT with more than 750,000 tests run; screens the core trisomies 21, 18, and 13, and (optionally) fetal sex, clinically relevant microdeletions, sex chromosome aneuploidies, and trisomies 16 and 22.

Detects trisomy 21 (Down syndrome)
Detects trisomy 18 (Edwards syndrome)
Detects trisomy 13 (Patau syndrome)
Detects sex chromosome abnormalities*
Reports fetal fraction
Reports fetal sex*
Multiple gestations†
Detects additional trisomies 22, 16*
Detects select microdeletions, such as 22q11.2 (DiGeorge syndrome)**
Performed as early as 9 weeks
~5 calendar day turnaround time
Genome-wide analysis of all chromosomes
Reports on any trisomy or monosomy
Detects subchromosomal abnormalities ≥ 7 Mb

MaterniT 21 PLUS, MaterniT GENOME, and informaSeq are laboratory-developed test developed and performed exclusively by Integrated Genetics. 

* Optional reporting     † informaSeq is validated for singleton and twin pregnancies     ** Optional reporting for MaterniT 21 PLUS

If you’ve not had a test and have questions about costs or coverage, use our estimator.

If you have already had a test performed, we can help answer questions about results.

Ask questions about genetic testing options or results, or schedule an appointment.

References

  1. Ehrich M, Tynan J, Mazloom A, Almasri E, McCullough R, Boomer T, et al. Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases. Genet Med. 2017 Jun 15. 1-6.